Zynerba Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
The Company’s cash and cash equivalent position as of March 31, 2019 was $68.3 million.
Read More
Category: Financial
MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results
MediPharm Labs Corp. will release its first quarter financial results for the three months ended March 31, 2019 on Friday, May 10, 2019.
Read More
Cara Therapeutics Reports First Quarter 2019 Financial Results
The Company reported a net loss of $22.0 million, or $0.56 per basic and diluted share, for the first quarter of 2019.
Read More
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019
Epidiolex U.S. reported a Q1 net sales of $33.5m.
Read More
Medtainer Inc. Financials update
The reason that the report has not been filed arises from the Company’s acquisition of the patents and trademark relating to its Medtainer products and a related website in June 2018 in exchange for shares of its common stock.
Read MoreGET LISTED
